SLC2A1 and Charcot-Marie-Tooth disease: Encoded by SLC2A1, GLUT1 is a high-affinity glucose transporter that has emerged as a promising target for CMT due to its significantly higher expression at the BBB compared to many other receptors and transporters—approximately 100-fold greater than the transferrin receptor (TfR) [181,182].